177 related articles for article (PubMed ID: 35103338)
1. Contrast-Enhanced Ultrasound Features of Adult Xp11.2 Translocation Renal Cell Carcinoma: Differential Diagnosis With Three Main Renal Cell Carcinoma Subtypes.
Ma W; Zhang F; Huang H; Wang W; Zhu Y; Lu Y; Guo H; Gan W
J Ultrasound Med; 2022 Nov; 41(11):2673-2685. PubMed ID: 35103338
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced ultrasound findings of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.
Wei S; Tian F; Xia Q; Huang P; Zhang Y; Xia Z; Wu M; Yang B
Cancer Imaging; 2019 Dec; 20(1):1. PubMed ID: 31892340
[TBL] [Abstract][Full Text] [Related]
3. The value of real-time contrast-enhanced ultrasound combined with CT enhancement in the differentiation of subtypes of renal cell carcinoma.
Liang RX; Wang H; Zhang HP; Ye Q; Zhang Y; Zheng MJ; Xue ES; Zhu YF
Urol Oncol; 2021 Dec; 39(12):837.e19-837.e28. PubMed ID: 34654644
[TBL] [Abstract][Full Text] [Related]
4. Papillary renal cell carcinoma and clear cell renal cell carcinoma: Differentiation of distinct histological types with contrast - enhanced ultrasonography.
Xue LY; Lu Q; Huang BJ; Li Z; Li CX; Wen JX; Wang WP
Eur J Radiol; 2015 Oct; 84(10):1849-56. PubMed ID: 26149528
[TBL] [Abstract][Full Text] [Related]
5. Dynamic Contrast-Enhanced CT Characterization of Xp11.2 Translocation/TFE3 Gene Fusions versus Papillary Renal Cell Carcinomas.
He J; Zhou K; Zhu B; Zhang G; Li X; Guo H; Gan W; Zhou Z; Liu T
Biomed Res Int; 2015; 2015():298679. PubMed ID: 26636097
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of subtypes of renal cell carcinoma with contrast-enhanced ultrasonography.
Xue LY; Lu Q; Huang BJ; Li CX; Yan LX; Wang WP
Clin Hemorheol Microcirc; 2016 Oct; 63(4):361-371. PubMed ID: 26598999
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-204-5p: A novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinoma.
Kurahashi R; Kadomatsu T; Baba M; Hara C; Itoh H; Miyata K; Endo M; Morinaga J; Terada K; Araki K; Eto M; Schmidt LS; Kamba T; Linehan WM; Oike Y
Cancer Sci; 2019 Jun; 110(6):1897-1908. PubMed ID: 31006167
[TBL] [Abstract][Full Text] [Related]
8. Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11.2 translocation renal cell carcinoma.
Liu N; Chen Y; Yang L; Shi Q; Lu Y; Ma W; Han X; Guo H; Li D; Gan W
Clin Transl Med; 2022 Apr; 12(4):e797. PubMed ID: 35452181
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of uncommon renal epithelial neoplasms: performances of fluorescence in situ hybridization.
Beaumont M; Dugay F; Kammerer-Jacquet SF; Jaillard S; Cabillic F; Mathieu R; Verhoest G; Bensalah K; Rioux-Leclercq N; Belaud-Rotureau MA;
Hum Pathol; 2019 Oct; 92():81-90. PubMed ID: 31437522
[TBL] [Abstract][Full Text] [Related]
10. Papillary renal cell carcinoma in contrast-enhanced ultrasound (CEUS) - A diagnostic performance study.
Mueller-Peltzer K; Negrao de Figueiredo G; Graf T; Rübenthaler J; Clevert DA
Clin Hemorheol Microcirc; 2019; 71(2):159-164. PubMed ID: 30562896
[TBL] [Abstract][Full Text] [Related]
11. Role of Contrast-Enhanced Ultrasound With the Enhancement Pattern and Qualitative Analysis for Differentiating Hypovascular Solid Renal Lesions.
Li J; Huang X; Wang L; Wang X; Li Y; Liu X; Ye N; Yang S; Nie F
Ultrasound Med Biol; 2024 Feb; 50(2):295-303. PubMed ID: 37996360
[TBL] [Abstract][Full Text] [Related]
12. Dynamic Computed Tomographic Features of Adult Renal Cell Carcinoma Associated With Xp11.2 Translocation/TFE3 Gene Fusions: Comparison With Clear Cell Renal Cell Carcinoma.
He J; Gan W; Liu S; Zhou K; Zhang G; Guo H; Zhu B
J Comput Assist Tomogr; 2015; 39(5):730-6. PubMed ID: 25955396
[TBL] [Abstract][Full Text] [Related]
13. Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant article.
Chen X; Yang Y; Gan W; Xu L; Ye Q; Guo H
Medicine (Baltimore); 2015 May; 94(19):e873. PubMed ID: 25984679
[TBL] [Abstract][Full Text] [Related]
14. Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients.
Agizamhan S; Qu F; Liu N; Sun J; Xu W; Zhang L; Guo H; Gan W
BMC Urol; 2018 Jun; 18(1):60. PubMed ID: 29890986
[TBL] [Abstract][Full Text] [Related]
15. MDCT findings of renal cell carcinoma associated with Xp11.2 translocation and TFE3 gene fusion and papillary renal cell carcinoma.
Woo S; Kim SY; Lee MS; Moon KC; Kim SH; Cho JY; Kim SH
AJR Am J Roentgenol; 2015 Mar; 204(3):542-9. PubMed ID: 25714283
[TBL] [Abstract][Full Text] [Related]
16. Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers.
Argani P; Hicks J; De Marzo AM; Albadine R; Illei PB; Ladanyi M; Reuter VE; Netto GJ
Am J Surg Pathol; 2010 Sep; 34(9):1295-303. PubMed ID: 20679884
[TBL] [Abstract][Full Text] [Related]
17. [Differential diagnosis between renal cell carcinoma associated with XP11.2 translocation/TFE gene fusion and papillary renal cell carcinoma based on CT and MRI findings].
Zhu Q; Zhu W; Wu J; Fu J; Chen W; Wang Z
Zhonghua Yi Xue Za Zhi; 2014 May; 94(19):1470-2. PubMed ID: 25143166
[TBL] [Abstract][Full Text] [Related]
18. The Value of Contrast-Enhanced Ultrasound in Diagnosing Small Renal Cell Carcinoma Subtypes and Angiomyolipoma.
Cao H; Fang L; Chen L; Zhan J; Diao X; Liu Y; Lu C; Zhang Z; Chen Y
J Ultrasound Med; 2022 Jun; 41(6):1415-1423. PubMed ID: 34499770
[TBL] [Abstract][Full Text] [Related]
19. Incidence and significance of psammoma bodies in Xp11.2 translocation renal cell carcinoma and papillary renal cell carcinoma.
Liu N; Qu F; Wei K; Gan W; Wang Z; Zhuang W; Agizamhan S; Ma W; Yang J; Chen M; Xu L; Guo H; Li D
Oncol Lett; 2019 Jul; 18(1):472-478. PubMed ID: 31289519
[TBL] [Abstract][Full Text] [Related]
20. Molecular-genetic analysis is essential for accurate classification of renal carcinoma resembling Xp11.2 translocation carcinoma.
Hayes M; Peckova K; Martinek P; Hora M; Kalusova K; Straka L; Daum O; Kokoskova B; Rotterova P; Pivovarčikova K; Branzovsky J; Dubova M; Vesela P; Michal M; Hes O
Virchows Arch; 2015 Mar; 466(3):313-22. PubMed ID: 25544614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
